newsfilter
← Latest News
Business Wire·

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GH

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced that on April 21, 2026, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock